Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation

Journal of Immunology

Volumn 169, Issue 8, 2002, Pages 4322-4331

  Mummert, Mark E ^a   Mummert, Diana ^a   Edelbaum, Dale ^a   Hui, Francis ^a   Matsue, Hiroyuki ^a   Takashima, Akira ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCURONIC ACID; HYALURONIC ACID; HYALURONIDASE; INTERLEUKIN 2; N ACETYLGLUCOSAMINE; SYNTHETASE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; EXTRACELLULAR MATRIX; FEMALE; GLYCOSAMINOGLYCAN METABOLISM; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0037108377     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.8.4322     Document Type: Article

References (60)

1. Tammi, R., J. A. Ripellino, R. U. Margolis, and M. Tammi. 1988. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J. Invest. Dermatol. 90:412.
2. Tammi, R., A. M. Saamanen, H. I. Maibach, and M. Tammi. 1991. Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J. Invest. Dermatol. 97:126.
3. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303.
4. Miyake, K., C. B. Underhill, J. Lesley, and P. W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69.
5. Hardingham, T. E. 1979. The role of link-protein in the structure of cartilage proteoglycan aggregates. Biochem. J. 177:237.
6. Watanabe, H., S. C. Cheung, N. Itano, K. Kimata, and Y. Yamada. 1997. Identification of hyaluronan-binding domains of aggrecan. J. Biol. Chem. 272:28057.
7. LeBaron, R. G., D. R. Zimmermann, and E. Ruoslahti. 1992. Hyaluronate binding properties of versican. J. Biol. Chem. 267:10003.
8. Delpech, B., and C. Halavent. 1981. Characterization and purification from human brain of a hyaluronic acid-binding glycoprotein, hyaluronectin. J. Neurochem. 36:855.
9. Rauch, U., L. Karthikeyan, P. Maurel, R. U. Margolis. and R. K. Margolis. 1992. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J. Biol. Chem. 267:19536.
10. Banerji, S., J. Ni, S. X. Wang, S. Clasper, J. Su, R. Tammi, M. Jones, and D. G. Jackson. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144:789.
11. Prevo. R., S. Banerji, D. J. Ferguson, S. Clasper, and D. G. Jackson. 2001. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276:19420.
12. Cheung, W. F., T. F. Cruz, and E. A. Turley. 1999. Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem. Soc. Trans. 27:135.
13. Itano, N., T. Sawai, M. Yoshida, P. Lenas, Y. Yamada, M. Imagawa, T. Shinomura, M. Hamaguchi, Y. Yoshida, Y. Ohnuki, et al. 1999. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 274:25085.
14. Weigel, P. H., V. C. Hascall, and M. Tammi. 1997. Hyaluronan synthases. J. Biol. Chem. 272:13997.
15. Roden, L., P. Campbell, J. R. Fraser, T. C. Laurent, H. Pertoft, and J. N. Thompson. 1989. Enzymic pathways of hyaluronan catabolism. Ciba Found. Symp. 143:60.
16. Frost, G. I., T. B. Csoka, T. Wong, and R. Stem. 1997. Purification, cloning, and expression of human plasma hyaluronidase. Biochem. Biophys. Res. Commun. 236:10.
17. Gmachl, M., S. Sagan, S. Ketter, and G. Kreil. 1993. The human sperm protein PH-20 has hyaluronidase activity. FEBS Lett. 336:545.
18. Lepperdinger, G., B. Strobl, and G. Kreil. 1998. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem. 273:22466.
19. Csoka, T. B., G. I. Frost, T. Wong, and R. Stern. 1997. Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett. 417:307.
20. Hardwick, C., K. Hoare, R. Owens, H. P. Hohn, M. Hook, D. Moore, V. Cripps, L. Austen, D. M. Nance, and E. A. Turley. 1992. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J. Cell Biol. 117:1343.
21. Hodge-Dufour, J., P. W. Noble, M. R. Horton, C. Bao, M. Wysoka, M. D. Burdick, R. M. Strieter, G. Trinchieri, and E. Puré. 1997. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J. Immunol. 159:2492.
22. Horton, M. R., M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. 1998. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J. Immunol. 160:3023.
23. McKee, C. M., M. B. Penno, M. Cowman, M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. 1996. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J. Clin. Invest. 98:2403.
24. Horton, M. R., C. M. McKee, C. Bao, F. Liao, J. M. Farber, J. Hodge-Dufour, E. Pure, B. L. Oliver, T. M. Wright, and P. W. Noble. 1998. Hyaluronan fragments synergize with interferon-γ to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J. Biol. Chem. 273:35088.
25. 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol. Biol. Cell 7:383.
26. Jalkanen, S., and M. Jalkanen. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:817.
27. Sleeman, J. P., K. Kondo, J. Moll, H. Ponta, and P. Herrlich. 1997. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J. Biol. Chem. 272:31837.
28. Toyama-Sorimachi, N., F. Kitamura, H. Habuchi, Y. Tobita, K. Kimata, and M. Miyasaka. 1997. Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells. J. Biol. Chem. 272:26714.
29. Mummert, M. E., M. Mohamadzadeh, D. I. Mummert, N. Mizumoto, and A. Takashima. 2000. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J. Exp. Med. 192:769.
30. Xu, S., K. Ariizumi, G. Caceres-Dittmar, D. Edelbaum, K. Hashimoto, P. R. Bergstresser, and A. Takashima. 1995. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J. Immunol. 154:2697.
31. Matsue, H., K. Matsue, M. Walters, K. Okumura, H. Yagita, and A. Takashima. 1999. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected "killer" dendritic cells. Nat. Med. 5:930.
32. Kumamoto, T., E. K. Huang, H. J. Paek, R. F. Valentini, and A. Takashima. 2002. Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat. Biotechnol. 20:64.
33. Mizumoto, N., T. Kumamoto, S. C. Robson, J. Sévigny, H. Matsue, K. Enjyoji, and A. Takashima. 2002. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 8:358.
34. Schaefer, B. C., M. F. Ware, P. Marrack, G. R. Fanger, J. W. Kappler, G. L. Johnson, and C. R. Monks. 1999. Live cell fluorescence imaging of T cell MEKK2: redistribution and activation in response to antigen stimulation of the T cell receptor. Immunity 11:411.
35. Menzel, E. J., and C. Farr. 1998. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett. 131:3.
36. Lyon, M., J. A. Deakin, and J. T. Gallagher. 1994. Liver heparan sulfate structure: a novel molecular design. J. Biol. Chem. 269:11208.
37. van den Born, J., K. Gunnarsson, M. A. Bakker, L. Kjellen, M. Kusche-Gullberg, M. Maccarana, J. H. Berden, and U. Lindahl. 1995. Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J. Biol. Chem. 270:31303.
38. Rozenberg, G. I., J. Espada, L. L. de Cidre, A. M. Eijan, J. C. Calvo, and G. E. Bertolesi. 2001. Heparan sulfate, heparin, and heparinase activity detection on polyacrylamide gel electrophoresis using the fluorochrome tris(2,2′-bipyridine) ruthenium (II). Electrophoresis 22:3.
39. Io thymocytes in vivo. Science 250: 1720.
40. Sconocchia, G., J. A. Titus, and D. M. Segal. 1997. Signaling pathways regulating CD44-dependent cytolysis in natural killer cells. Blood 90:716.
41. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
42. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.-J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
43. Galandrini, R., E. Galluzzo, N. Albi, C. E. Grossi, and A. Velardi. 1994. Hyaluronale is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J. Immunol. 153:21.
44. Lesley, J., and R. Hyman. 1992. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur. J. Immunol. 22:2719.
45. Lesley, J., N. Howes, A. Perschl, and R. Hyman. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180:383.
46. 4 integrin on activated Langerhans cells: analysis of adhesion molecules on Langerhans cells relating to their migration from skin to draining lymph nodes. J. Invest. Dermatol. 100:143.
47. Weiss, J. M., J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxis, N. Howells, E. Schöpf, H. Ponta, P. Herrlich, et al. 1997. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137:1137.
48. Camenisch, T. D., A. P. Spicer, T. Brehm-Gibson, J. Biesterfeldt, M. L. Augustine, A. Calabro, Jr., S. Kubalak, S. E. Klewer, and J. A. McDonald. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106:349.
49. Simpson, M. A., C. M. Wilson, L. T. Furcht, A. P. Spicer, T. R. Oegema, Jr., and J. B. McCarthy. 2002. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells. J. Biol. Chem. 277:10050.
50. Cumberbatch, M., R. J. Dearman, and I. Kimber. 1996. Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison. Arch. Dermatol. Res. 288:739.
51. Osada, A., H. Nakashima, M. Furue, and K. Tamaki. 1995. Up regulations of CD44 expression by tumor necrosis factor-α is neutralized by interleukin 10 in Langerhans cells. J. Invest. Dermatol. 105:124.
52. Camp, R. L., A. Scheynius, C. Johansson, and E. Puré. 1993. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178:497.
53. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90:2217.
54. Kaya, G., I. Rodriguez, J. L. Jorcano, P. Vassalli, and I. Stamenkovic. 1999. Cutaneous delayed-type hypersensitivity response is inhibited in transgenic mice with keratinocyte-specific CD44 expression defect. J. Invest. Dermatol. 113:137.
55. Kaya, G., I. Rodriguez, J. L. Jorcano, P. Vassalli, and I. Stamenkovic. 1997. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 11:996.
56. Termeer, C. C., J. Hennies, U. Voith, T. Ahrens, J. M. Weiss, P. Prehm, and J. C. Simon. 2000. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165:1863.
57. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195:99.
58. Wrenshall, L. E., F. B. Cerra, A. Carlson, F. H. Bach, and J. L. Platt. 1991. Regulation of murine splenocyte responses by heparan sulfate. J. Immunol. 147: 455.
59. Kodaira, Y., S. K. Nair, L. E. Wrenshall, E. Gilboa, and J. L. Platt. 2000. Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J. Immunol. 165:1599.
60. Johnson, G. B., G. J. Brunn, Y. Kodaira, and J. L. Platt. 2002. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168:5233.